507 followers
RT @jvalentingg: Newly diagnosed patients with CP CML receiving bosutinib or imatinib can preserve or improve HRQoL. Proud to be part of th…
RT @jvalentingg: Newly diagnosed patients with CP CML receiving bosutinib or imatinib can preserve or improve HRQoL. Proud to be part of th…
RT @jvalentingg: Newly diagnosed patients with CP CML receiving bosutinib or imatinib can preserve or improve HRQoL. Proud to be part of th…
RT @jvalentingg: Newly diagnosed patients with CP CML receiving bosutinib or imatinib can preserve or improve HRQoL. Proud to be part of th…
Newly diagnosed patients with CP CML receiving bosutinib or imatinib can preserve or improve HRQoL. Proud to be part of this trial. https://t.co/CJDcW70LMP